Clinical Trial Update: Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism [NA]

View source ↗

Summary

A clinical trial is recruiting to assess thyroid hormone replacement after coronary artery bypass grafting in patients with subclinical hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subclinical Hypothyroidism

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Subclinical Hypothyroidism | NA | Status: RECRUITING